Japan’s iPS cell innovations and regulatory reforms, along with U.S. approvals in gene‑cell therapies, propel growth in regenerative medicine for cancer, cardiovascular, and neurological conditions https://www.einpresswire.com/article/833510964/cell-regeneration-medicine-market-poised-for-breakthrough-growth-datam-intelligence